Evidence map›Paper›PMID 34318626›Full record

Observational studyCancer medicine2021

Prevalence of frailty and prediction of mortality in Chinese cancer patients using a frailty index-based clinical algorithm-A multicentre study.

Xi Jin, Yue Ren, Li Shao, Zengqing Guo, Chang Wang, Ying He, Lan Zhou, Minghua Cong, Hu Ma, Wei Wang and 10 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Cancer medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Physiological Systems in Promoting Frailty.Comprehensive Physiology · 2022
    Review
  14. Article
  15. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 15 institutions in 1 country.

Xi JinDepartment of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.ORCID 0000-0002-2975-977X
Yue RenDepartment of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Li ShaoInstitute of Translational Medicine, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
Zengqing GuoDepartment of Medical Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
Chang WangCancer Center of the First Hospital of Jilin University, Changchun, China.
Ying HeDepartment of Clinical Nutrition, Chongqing General Hospital, Chongqing, China.
Lan ZhouDepartment of Nutrition, Third Affiliated Hospital of Kunming Medical College, Tumor Hospital of Yunnan Province, Kunming, China.
Minghua CongComprehensive Oncology Department, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Hu MaDepartment of Oncology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Wei WangCancer Center, The First People's Hospital of Foshan, Foshan, China.
Chunling ZhouDepartment of Clinical Nutrition, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, China.
Yongdong FengDepartment of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yi BaDepartment of Gastrointestinal Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Jianguo GaoDepartment of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Miaomiao LuDepartment of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Mengmeng ZhangDepartment of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Xue-Wei GuDepartment of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Chunhua SongDepartment of Epidemiology and Statistics, College of Public Health, Zhengzhou University, Zhengzhou, China.ORCID 0000-0001-6028-5923
Hongxia XuDepartment of Nutrition, Department of Nutrition, Daping Hospital & Research Institute of Surgery, Third Military Medical University, Chongqing, China.ORCID 0000-0001-5215-734X
Hanping ShiDepartment of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University/The 9th Clinical Medical College, Peking University, Beijing, China.ORCID 0000-0003-4514-8693
First Affiliated Hospital Zhejiang University · CNAffiliated Hospital of Hangzhou Normal University · CNArmy Medical University · CNCapital Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNFirst People's Hospital of Chongqing · CNFirst People's Hospital of Foshan · CNFujian Medical University · CNHarbin Medical University · CNJilin University · CNKunming Medical University · CNTianjin Medical University Cancer Institute and Hospital · CNTongji Hospital · CNZhengzhou University · CNZunyi Medical University · CN

Funding

National Key Research and Development Program 2017YFC1309200
6 · The paper itself

Abstract

purposeTo investigate the frailty status in Chinese cancer patients through establishing a novel prediction algorithm.

methodsThe percentage of frailty in various age groups, locations, and tumor types in Chinese cancer patients was investigated. The prediction capacity of frailty on mortality of Chinese cancer patients was analysed by the frailty index composing of routine laboratory data (FI-LAB) accessible from a blood test and calculated as the ratio of abnormal factors to 22 total variables. The establishment of a novel algorithm, MCP (mortality of cancer patients), to predict the 5-year mortality in Chinese cancer patients was accomplished and the algorithm's prediction capacity was tested in the training and validation sets using receiver operating characteristic (ROC) analysis.

resultsWe found that the risk of death in cancer patients can be successfully identified through FI-LAB. The univariable and multivariable Cox regression were used to evaluate the effect of frailty on death. In the 5-year follow-up, 20.6% of the 2959 participants (age = 55.8 ± 11.7 years; 43.5% female) died, while the mean FI-LAB score in baseline was 0.23 (standard deviation = 0.13; range = 0-0.73). Frailty (after adjusting for gender, age, and other confounders) directly correlated with an increased risk of death, hazard ratio of 12.67 (95% confidence interval [CI]: 7.19, 22.31), compared to those without frailty. In addition, the MCP algorithm (MCP) = 3.678 × FI-LAB + 1.575 × sex + 1.779 × first tumor node metastasis staging, presented an area under the ROC (AUC) of 0.691 (95% CI: 0.656-0.726) and 0.648 (95% CI: 0.613-0.684) in the training and validation sets, respectively.

conclusionFrailty as defined by FI-LAB was common and indicated a significant death risk in cancer patients. Our novel developed algorithm MCP had a passable prediction capacity on 5-year MCP.

Indexed as

AdultAgedAlgorithmsChinaFeasibility StudiesFemaleFollow-Up StudiesFrailtyGeriatric AssessmentHumansMaleMiddle AgedNeoplasmsPrevalenceProspective StudiesRisk Assessmentblood testcancerfrailtymortality

Identifiers

PMID34318626
PMCPMC8446570
OpenAlexW3197928745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.